Published in Arch Neurol on November 01, 1998
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA (2008) 7.35
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging (2011) 3.83
Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. Am J Clin Nutr (2014) 2.81
Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev (2008) 2.62
Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J Biol Chem (2009) 2.49
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One (2010) 1.92
Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study. Circ Cardiovasc Genet (2009) 1.71
Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiatry (2002) 1.63
Identifying and validating biomarkers for Alzheimer's disease. Trends Biotechnol (2010) 1.59
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging (2008) 1.57
PENN biomarker core of the Alzheimer's disease Neuroimaging Initiative. Neurosignals (2007) 1.54
Nutrition and depression: implications for improving mental health among childbearing-aged women. Biol Psychiatry (2005) 1.46
Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A (2013) 1.46
Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol (2016) 1.39
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr (2008) 1.37
Dietary approaches that delay age-related diseases. Clin Interv Aging (2006) 1.37
Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet (2009) 1.33
Imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci U S A (2002) 1.30
Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis (2006) 1.25
Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol (2010) 1.23
The role of B vitamins in preventing and treating cognitive impairment and decline. Adv Nutr (2012) 1.18
Vitamin D as a marker of cognitive decline in elderly Indian population. Ann Indian Acad Neurol (2015) 1.16
One walk a year to 1000 within a year: continuous in-home unobtrusive gait assessment of older adults. Gait Posture (2011) 1.16
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.15
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease? Exp Gerontol (2010) 1.12
Blood-based biomarkers of Alzheimer's disease: challenging but feasible. Biomark Med (2010) 1.12
Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study. Neurology (2004) 1.11
Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci (2011) 1.09
Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimers Dement (2005) 1.07
Diverse metabolic model parameters generate similar methionine cycle dynamics. J Theor Biol (2007) 1.06
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis (2009) 1.06
Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet. Exp Gerontol (2009) 1.05
Genetic architecture of vitamin B12 and folate levels uncovered applying deeply sequenced large datasets. PLoS Genet (2013) 1.04
Homocysteine- and cysteine-mediated growth defect is not associated with induction of oxidative stress response genes in yeast. Biochem J (2006) 1.04
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics. J Neural Transm (Vienna) (2011) 1.04
Sulfur as a signaling nutrient through hydrogen sulfide. Annu Rev Nutr (2014) 1.04
Adherence to a Mediterranean diet and risk of incident cognitive impairment. Neurology (2013) 1.02
The role of dimerization in prion replication. Biophys J (2002) 1.02
Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism. PLoS One (2013) 1.02
Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease. Antioxid Redox Signal (2007) 1.01
Patterns of dietary supplement usage in demographically diverse older people. Altern Ther Health Med (2005) 1.01
Polymorphisms in 1-carbon metabolism, epigenetics and folate-related pathologies. J Nutrigenet Nutrigenomics (2012) 1.01
Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology (2012) 1.00
Fraction of total plasma vitamin B12 bound to transcobalamin correlates with cognitive function in elderly Latinos with depressive symptoms. Clin Chem (2008) 1.00
Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol (2009) 0.99
One-carbon metabolism and Alzheimer's disease: focus on epigenetics. Curr Genomics (2010) 0.99
Folic acid, ageing, depression, and dementia. BMJ (2002) 0.99
Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: the health in men study. Mol Psychiatry (2011) 0.97
Neuronutrition and Alzheimer's disease. J Alzheimers Dis (2010) 0.97
The logic of the hepatic methionine metabolic cycle. Biochim Biophys Acta (2009) 0.97
Cognitive impairment after cerebrovascular stroke: Relationship to vascular risk factors. Neuropsychiatr Dis Treat (2009) 0.97
Hydrogen sulfide inhibits homocysteine-induced endoplasmic reticulum stress and neuronal apoptosis in rat hippocampus via upregulation of the BDNF-TrkB pathway. Acta Pharmacol Sin (2014) 0.97
Homocysteine and cognitive function in elderly people. CMAJ (2004) 0.95
Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. J Alzheimers Dis (2008) 0.95
DNA methylation, a hand behind neurodegenerative diseases. Front Aging Neurosci (2013) 0.94
Extracellular transsulfuration generates hydrogen sulfide from homocysteine and protects endothelium from redox stress. Am J Physiol Heart Circ Physiol (2010) 0.94
Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease. FASEB J (2010) 0.94
Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat (2010) 0.94
Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport (2011) 0.93
Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy. Epilepsia (2007) 0.90
Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment. Aging Dis (2015) 0.90
Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: a voxel-based morphometry study. Brain Res (2008) 0.89
Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study. Brain (2013) 0.89
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial. Neurology (2009) 0.88
Homocysteine and related genetic polymorphisms in Down's syndrome IQ. J Neurol Neurosurg Psychiatry (2005) 0.88
Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease. Dement Geriatr Cogn Dis Extra (2011) 0.88
Automatic volumetry on MR brain images can support diagnostic decision making. BMC Med Imaging (2008) 0.87
Hyperhomocysteinemia: a new risk factor for Alzheimer disease? Arch Neurol (1998) 0.86
Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics. Curr Alzheimer Res (2012) 0.86
Medications and diet: protective factors for AD? Alzheimer Dis Assoc Disord (2006) 0.85
Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID). Biochim Biophys Acta (2015) 0.85
Cobalt cystathionine β-synthase: a cobalt-substituted heme protein with a unique thiolate ligation motif. Inorg Chem (2011) 0.84
Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease. Dement Geriatr Cogn Disord (2008) 0.84
Beneficial effects of folic acid on enhancement of memory and antioxidant status in aged rat brain. Cell Mol Neurobiol (2010) 0.84
Association between intake of B vitamins and cognitive function in elderly Koreans with cognitive impairment. Nutr J (2014) 0.84
Translational regulation of human methionine synthase by upstream open reading frames. Biochim Biophys Acta (2007) 0.84
Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging (2014) 0.83
Integrating retrogenesis theory to Alzheimer's disease pathology: insight from DTI-TBSS investigation of the white matter microstructural integrity. Biomed Res Int (2015) 0.83
Folate and vitamin B12 status of a multiethnic adult population. J Natl Med Assoc (2006) 0.83
Homocysteine transport by human aortic endothelial cells: identification and properties of import systems. Arch Biochem Biophys (2006) 0.83
Biological risk of older adults with visual impairments. J Nutr Health Aging (2011) 0.83
Impeded electron transfer from a pathogenic FMN domain mutant of methionine synthase reductase and its responsiveness to flavin supplementation. Biochemistry (2008) 0.83
The many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism. Antioxid Redox Signal (2007) 0.82
Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study. J Acad Nutr Diet (2014) 0.82
Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota. J Neurovirol (2015) 0.82
Cerebrospinal fluid and blood biomarkers in Alzheimer's disease. World J Psychiatry (2011) 0.81
Gender-specific impact of personal health parameters on individual brain aging in cognitively unimpaired elderly subjects. Front Aging Neurosci (2014) 0.81
Effect of the disease-causing R266K mutation on the heme and PLP environments of human cystathionine β-synthase. Biochemistry (2012) 0.81
Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future. Aging health (2008) 0.80
Neuroimaging, nutrition, and iron-related genes. Cell Mol Life Sci (2013) 0.80
Association analysis of CbetaS 844ins68 and MTHFD1 G1958A polymorphisms with Alzheimer's disease in Chinese. J Neural Transm (Vienna) (2010) 0.80
Vitamin status and cognitive function in a long-term care population. BMC Geriatr (2005) 0.80
Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity? J Neuroinflammation (2006) 0.80
A proteomics study reveals a predominant change in MaoB expression in platelets of healthy volunteers after high protein meat diet: relationship to the methylation cycle. J Neural Transm (Vienna) (2011) 0.80
Cerebral perfusion and oxygenation are impaired by folate deficiency in rat: absolute measurements with noninvasive near-infrared spectroscopy. J Cereb Blood Flow Metab (2011) 0.80
Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial. Contemp Clin Trials (2012) 0.80
Interaction of Memantine with Homocysteine on the Apoptosis in the Rat Hippocampus cells. Int J Mol Cell Med (2012) 0.79
Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds. Eur J Nutr (2007) 0.79
Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet (2000) 5.61
Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med (1997) 5.35
Homocysteine and cardiovascular disease. Annu Rev Med (1998) 4.69
Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet (1992) 3.94
Properties of plasmids responsible for production of extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1991) 3.90
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA (1997) 3.87
The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta (1984) 3.58
Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. J Virol (1999) 3.32
Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr (2001) 3.04
Subclinical slipped capital femoral epiphysis. Relationship to osteoarthrosis of the hip. J Bone Joint Surg Am (1997) 2.97
Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia (2007) 2.96
Ontogeny of orientation flight in the honeybee revealed by harmonic radar. Nature (2000) 2.86
A simple method for the isolation of adrenal chromaffin granules on a large scale. Biochem J (1967) 2.84
Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. Biochem J (1967) 2.82
Reduced antiretroviral drug susceptibility among patients with primary HIV infection. JAMA (1999) 2.82
Techniques of endopyelotomy. Br J Urol (1998) 2.68
Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr (2000) 2.53
Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J (1973) 2.53
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J Clin Microbiol (1994) 2.47
The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr (2000) 2.45
The blind-loop syndrome. Monogr Surg Sci (1967) 2.43
Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy. Lancet (1979) 2.42
Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr (1998) 2.41
Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet (1995) 2.36
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA (1995) 2.31
Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation (1998) 2.31
Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature (1967) 2.29
Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci (2001) 2.13
Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci U S A (2000) 2.13
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol Rev (1982) 2.11
The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther (2012) 2.10
Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol (1992) 2.10
beta-Lactamases and beta-lactam resistance in Escherichia coli. Antimicrob Agents Chemother (1985) 2.09
Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem (1993) 2.07
Abnormal function of potassium channels in platelets of patients with Alzheimer's disease. Lancet (1998) 2.07
Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience (1984) 2.05
Integrated healthcare: a way forward for the next five years? A discussion document from the Prince of Wales's Initiative on Integrated Medicine. J Altern Complement Med (1998) 2.05
Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun (2011) 2.04
Analysis of double-stranded DNA by capillary electrophoresis with laser-induced fluorescence detection using the monomeric dye SYBR green I. Anal Biochem (1995) 2.03
Secretion from the adrenal medulla: biochemical evidence for exocytosis. Br J Pharmacol Chemother (1967) 2.03
Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem (1993) 2.01
Mediators of long-term memory performance across the life span. Psychol Aging (1996) 2.01
The flight paths of honeybees recruited by the waggle dance. Nature (2005) 2.01
Exhaled nitric oxide measurements: clinical application and interpretation. Thorax (2006) 2.01
Civilian vascular injuries: a critical appraisal of three decades of management. Ann Surg (1970) 1.97
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia (2003) 1.96
IscA, an alternate scaffold for Fe-S cluster biosynthesis. Biochemistry (2001) 1.93
Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment. Cancer Res (1989) 1.91
Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes. Antimicrob Agents Chemother (1993) 1.86
Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med (1989) 1.85
Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr (2001) 1.84
Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (1997) 1.84
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease. Brain (2002) 1.81
Serum total homocysteine and coronary heart disease. Int J Epidemiol (1995) 1.79
Endopyelotomy for horseshoe and ectopic kidneys. J Urol (1998) 1.76
Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia (1995) 1.76
An aerial netting study of insects migrating at high altitude over England. Bull Entomol Res (2004) 1.75
Ultrastructural studies on the adrenal medulla of golden hamster: origin and fate of secretory granules. Z Zellforsch Mikrosk Anat (1972) 1.74
Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol (2000) 1.73
Congenital constriction band syndrome causing ulnar nerve palsy: early diagnosis and surgical release with long-term follow-up. J Hand Surg Am (2001) 1.73
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry (2001) 1.70
Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience (1995) 1.68
Open surgical exploration after failed endopyelotomy: a 12-year perspective. J Urol (1997) 1.68
Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67
Percutaneous transperitoneal approach to a pelvic kidney for endourological removal of staghorn calculus. J Urol (1985) 1.67
Purification and characterization of bovine brain type I phosphatidylinositol kinase. Eur J Biochem (1990) 1.67
Gangrene and Fournier's gangrene. Urol Clin North Am (1992) 1.63
Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy. Neuroscience (1984) 1.60
Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr (1997) 1.58
Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (1997) 1.58
Diseases of meaning, manifestations of health, and metaphor. J Altern Complement Med (1999) 1.56
Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Acta Radiol (2001) 1.55
Rhabdoid tumor of the central nervous system. Med Pediatr Oncol (1991) 1.54
Plasma total homocysteine levels during short-term iatrogenic hypothyroidism. J Clin Endocrinol Metab (2000) 1.54
Amygdala input to medial prefrontal cortex (mPFC) in the rat: a light and electron microscope study. Brain Res (1996) 1.54
Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem (1992) 1.53
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure (1997) 1.52
The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.52
Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material. J Neurosci (1984) 1.51
A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis (1998) 1.50
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol (1998) 1.49
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience (1995) 1.48
Elevated plasma levels of reduced homocysteine in common variable immunodeficiency--a marker of enhanced oxidative stress. Eur J Clin Invest (1997) 1.48
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr (1996) 1.47